Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

A tolerogenic role for transitional dendritic cells in inflammation and cancer

FOXP3+ regulatory T (Treg) cells are pivotal for peripheral tolerance and immune suppression. We show that the skin-derived cytokine TSLP promotes GATA3-expressing effector Treg cells through a specific migratory DC2 subtype derived from transitional dendritic cells whose function requires OX40L, identifying a previously unrecognized tolerogenic axis across contexts of inflammation and cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Identification of Thy1 and CD8a as surface markers for TSLP-activated tDC2s.

References

  1. Whibley, N., Tucci, A. & Powrie, F. Regulatory T cell adaptation in the intestine and skin. Nat. Immunol. 20, 386–396 (2019). This review discusses how Treg cells adapt to the unique microenvironments of barrier sites, covering their development, phenotype and function.

    Article  CAS  PubMed  Google Scholar 

  2. Ebina-Shibuya, R. & Leonard, W. J. Role of thymic stromal lymphopoietin in allergy and beyond. Nat. Rev. Immunol. 23, 24–37 (2023). This review highlights recent advances in TSLP biology and its roles in allergic, infectious and inflammatory diseases and in cancer.

    Article  CAS  PubMed  Google Scholar 

  3. Yao, W. et al. Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment. JCI Insight 7, e161438 (2022). This study reports that TSLP promotes GATA3+ Treg cell generation and immune suppression in cutaneous melanoma through TSLPR-expressing DCs.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cabeza-Cabrerizo, M., Cardoso, A., Minutti, C. M., Pereira da Costa, M. & Reise Sousa, C. Dendritic cells revisited. Annu. Rev. Immunol. 39, 131–166 (2021). This review summarizes mouse and human cDC subsets, including their development, phenotype and function.

    Article  CAS  PubMed  Google Scholar 

  5. Sulczewski, F. B. et al. Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nat. Immunol. 24, 1265–1280 (2023). This study reports that tDCs share a lymphoid origin with pDCs and can differentiate into ESAM+ tDC2s, distinct from pre-DC2-derived cDC2s.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Guivarch, M. et al. TSLP promotes GATA3-expressing effector regulatory T cells via DC2 derived from transitional DCs. Nat. Immunol. https://doi.org/10.1038/s41590-025-02400-7 (2026).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A tolerogenic role for transitional dendritic cells in inflammation and cancer. Nat Immunol (2026). https://doi.org/10.1038/s41590-026-02417-6

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41590-026-02417-6

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer